SESebhat Erqou

Sebhat Erqou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sebhat Erqou has a total of 177 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Developing machine learning models to improve cardiovascular risk prediction for people living with HIV

    by Hari Dandapani, Yi-Yun Chen, Michael Kwok, Vrishali Lopes, Christopher Halladay, Gerald S. Bloomfield, Christoper T. Longenecker, Jennifer L. Sullivan, Gaurav Choudhary, James L. Rudolph, et al.

  • Multidimensional Social Adversity and Mortality in People With HIV Infection and Heart Failure: Insights From NYC Health + Hospitals HIV–Heart Failure Cohort

    by Yi-Yun Chen, Pawel Borkowski, Luca Biavati, Natalia Nazarenko, Matthew Parker, Amrin Kharawala, Coral Vargas-Pena, Ishmum Chowdhury, Joshua Bock, Vibhor Garg, et al.

    BACKGROUND: Heart failure is an increasingly common comorbidity among people with HIV infection, complicating care and heightening the vulnerability of this population to social adversity (SA). However, the impact of different SA domains on outcomes in this population remains poorly understood. METHODS: We analyzed data on people with HIV infection and heart failure from the NYC 4H (NYC Health + Hospitals HIV–Heart Failure) cohort. Baseline multidimensional SA was assessed by licensed clinical social workers using standardized evaluations and grouped into 5 domains: economic hardship, health care access barriers, neighborhood or built environment instability, social support challenge, and psychobehavioral instability. We used multivariable adjusted Cox models to estimate hazard ratios (HRs) of all-cause, cardiovascular, and infection-related mortality and logistic regression to estimate odds ratios of 6-month rehospitalization risk. RESULTS: Among 1044 participants (62.9% male; mean age, 61.6 years), 601 (58%) reported at least 1 SA: economic hardship (n=130), limited health care access (n=155), unstable housing (n=129), social support challenge (n=179), or psychobehavioral instability (n=438). Over a mean follow-up of 3.8 years, exposure to any SA was associated with higher all-cause mortality (HR, 4.32 [95% CI, 3.03–6.14]), cardiovascular mortality (HR, 4.05 [95% CI, 2.17–6.83]), and infection-related mortality (HR, 2.37 [95% CI, 1.23–4.56]). Social support challenge (HR, 2.19 [95% CI, 1.35–3.55]) and psychobehavioral instability (HR, 1.96 [95% CI, 1.24–3.11]) were associated with higher cardiovascular mortality. Economic hardship (HR, 2.40 [95% CI, 1.22–4.70]) and social support challenge (HR, 3.09 [95% CI, 1.75–5.48]) were associated with higher infection-related mortality. Compared with patients without SA, those with environmental instability, psychobehavioral instability, or social support challenges had a 73% (adjusted odds ratio, 1.73 [95% CI, 1.15–2.06]), 75% (adjusted odds ratio, 1.75 [95% CI, 1.31–2.35]), and 44% (adjusted odds ratio, 1.44 [95% CI, 1.00-2.06]) higher risk of rehospitalization within 6 months, respectively. CONCLUSIONS: SA was significantly associated with mortality and rehospitalization among people with HIV infection and heart failure, with domain-specific pathways influencing specific outcomes. Multidimensional assessment of SA may offer a framework for domain-specific risk stratification in people with HIV infection and heart failure.


  • Estimating the degree of cardiovascular disease risk under-prediction in people with HIV by existing risk models: an updated meta-analysis

    by Michael Kwok, Hari Dandapani, Nouran Ibrahim, Gerald S. Bloomfield, Samir Patel, Ali Ahmed, Jennifer L Sullivan, Gaurav Choudhary, James L. Rudolph, Wen-Chih Wu, et al.

    Background: The application of cardiovascular disease (CVD) risk models in people with HIV (PWH) may be limited due to concerns that the models tend to underestimate risk in this population. We conducted an updated meta-analysis to assess the degree of CVD risk under prediction in PWH by existing CVD risk models. Methods: We searched electronic databases and the reference lists of relevant articles. Data were abstracted using standardized forms. Calibration data included observed: expected ratios, which were graphically summarized. Weighted-regression models were fitted to estimate the relationship between observed and expected event rates across studies. Discrimination data included C -statistics which were pooled using random-effects model meta-analysis. Results: Sixteen publications reporting data on 97 945 PWH (mean age, 41 years; 75% male) were included. The risk scores tended to underpredict CVD risk in PWH, especially for individuals with lower expected risk. For PWH with expected 10-year CVD risk of 3%, the risk scores can underestimate risk by 71% on average. By contrast, for PWH with 6% and 9% expected 10-year CVD risk, the underestimation is by ~23% and ~7%, respectively. The risk scores had moderate performance in discrimination (pooled C -statistic values ranged from 0.71 to 0.82). There was substantial heterogeneity across studies and risk models. The 10-year models of the American Joint Societies Pooled Cohort Equation (PCE-10) and the Framingham Risk Score (FRS-10) had better calibration. Conclusions: Extant risk scores underpredict CVD risk in PWH, especially for individuals with lower expected risk, suggesting a need for implementation of HIV-specific calibration factors in this population. PCE-10 and FRS-10 showed better calibration.


  • Open Access

    Systemic inflammation, myocardial fibrosis, and subclinical cardiovascular disease in people living with HIV

    by MaryElizabeth Simkevich, Yi-Yun Chen, Melanie Parent, Yash Patel, Syed Hashim Bokhari, Lan Jiang, Gerald S. Bloomfield, James L. Rudolph, John McGeary, Gaurav Choudhury, et al.


  • Open Access

    Multi-dimensional Social Adversity and Mortality Outcome in People Living With HIV and Heart Failure: Insights from NYC Health + Hospitals HIV-Heart Failure cohort

    by Yi-Yun Chen, Pawel Borkowski, Luca Biavati, Natalia Nazarenko, Matthew Parker, Amrin Kharawala, Coral Vargas-Pena, Ishmum Chowdhury, Joshua Bock, Vibhor Garg, et al.

    Background: Heart failure (HF) is an increasingly common comorbidity among people living with HIV (PLHIV), complicating care and heightening vulnerability of this population to social adversity (SA). However, the impact of different SA domains on outcomes in this population remains poorly understood. Methods: We analyzed data on PLHIV with HF from the NYC Health + Hospitals HIV-Heart Failure cohort. Baseline multidimensional SA was assessed by licensed clinical social workers using standardized evaluations and grouped into five domains: (1) economic hardship, (2) healthcare access barriers, (3) neighborhood/built environment instability, (4) social support challenge, and (5) Psycho-behavioral instability. We used multivariable adjusted Cox models to estimate hazard ratios (HRs) of all-cause, cardiovascular, and infection-related mortality; and logistic regression to estimate odds ratios (ORs) of 6-month rehospitalization risk. Results: Among participants 1044 (62.9% males, mean age: 61.6 years), 601 (58%) reported at least 1social adversities: economic hardship (n=130), limited healthcare access (n=155), unstable housing (n=129), social support challenge (n=179), or psycho-behavioral instability (n=438). Over a mean follow up of 3.8 years, exposure to any SA was associated with higher all-cause mortality (HR 4.32; 95% confidence interval [CI] 3.03–6.14), CV mortality (HR 4.05; 95% CI 2.17–6.83), and infection-related mortality (HR 2.37; 95% CI 1.23–4.56). Social support challenge (HR 2.19; 95% CI 1.35–3.55) and psycho-behavioral instability (HR 1.96; 95% CI 1.24–3.11) were associated with higher CV mortality; economic hardship (HR 2.40; 95% CI 1.22–4.70) and social support challenge (HR 3.09; 95% CI 1.75–5.48) were associated with higher infection-related mortality. Compared with patients without SA, those with an environment instability, psycho-behavioral instability, or social support challenges had a 73% (aOR 1.73; 95% CI, 1.15–2.06), 75% (aOR 1.75; 95% CI, 1.31–2.35), and 44% (aOR 1.44; 95% CI, 1.00-2.06) higher risk of rehospitalization within 6 months, respectively. Conclusion: SA was significantly associated with mortality and rehospitalization among PLHIV with HF, with domain-specific pathways influencing specific outcomes. A multidimensional assessment of social vulnerability may be useful to risk-stratify HF mortality risk in PLHIV.

  • Open Access

    Re-evaluating Fasting Guidelines for Invasive Cardiac Procedures: A Systematic Review and Meta-analysis of Randomized Clinical Trials

    by Sebhat Erqou, Michael Kwok, Yongdeok Shin, Mohammed Motaweih, Eric Heinz, Aaron Schatz, Anna Tomdio, Luis A. Guzman

  • Open Access

    Gestational Diabetes Mellitus and Heart Failure

    by Eric K. Broni, Sebhat Erqou, Ravi Retnakaran, Allison G. Hays, Justin B. Echouffo-Tcheugui


  • Open Access

    Cardiovascular Risk Prediction Scores in Type 1 Diabetes

    by Sebhat Erqou, Ahmed Shahab, Fayez H. Fayad, Mohammed Haji, Matthew F. Yuyun, Jacob Joseph, Wen-Chih Wu, Amanda I. Adler, Trevor J. Orchard, Justin B. Echouffo-Tcheugui


  • Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension

    by Chan Woo Kim, Mohammed Haji, Vrishali V. Lopes, Christopher Halladay, Jennifer L. Sullivan, David Ross, Karen Slazinski, Tracey H. Taveira, Anupama Menon, Melissa Gaitanis, et al.


  • Open Access

    Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV

    by Mohammed Haji, Michael Capilupi, Michael Kwok, Nouran Ibrahim, Gerald S. Bloomfield, Christopher T. Longenecker, Maria C. Rodriguez-Barradas, Chester N. Ashong, Eric Jutkowitz, Tracey H. Taveira, et al.

    The widespread use of effective antiretroviral therapies (ARTs) has led to increased survivorship among people living with HIV. Therefore, people living with HIV are experiencing an increased prevalence of age-related disease, such as cardiovascular disease (CVD).1,2 The increase in CVD in this population has been attributed to multiple factors, including increasing age, the increase in burden of traditional CVD factors and psychosocial risk factors, the long-term metabolic effects of ART, and the low-grade immune activation of chronic HIV.1,3-8